ArticleCancers2022

Characterization of Immunoactive and Immunotolerant CD4+ T Cells in Breast Cancer by Measuring Activity of Signaling Pathways That Determine Immune Cell Function.

Yvonne Wesseling-Rozendaal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.